CompletedN/ADMT

Prospective Stratification of Infectious Risks in Multiple Sclerosis

Sponsored by University Hospital, Basel, Switzerland

NCT ID
NCT04036097
Target Enrollment
298 participants
Start Date
2019-04-10
Est. Completion
2023-12-31

About This Study

This monocentric study is to identify factors that increase the susceptibility for infections and establish a questionnaire-based infection score that allows a prospective stratification for infectious risks in patients with multiple sclerosis (MS) (InRIMS-Study). The study will utilize a validated, MS-adapted questionnaire and infection diary from the Airway Infection Susceptibility (AWIS) study in a regularly followed, prospective cohort of MS patients. It is a nested project of the prospective observational Swiss MS Cohort (SMSC) and SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation) studies.

Conditions Studied

Multiple Sclerosis

Interventions

  • MS-adapted AWIS questionnaire (MS-AWIS)
  • infection diary (MS-AWIS diary)

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Signed informed consent form (ICF) for the InRIMS-study and Swiss MS Cohort (SMSC) and/or Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT) study

Exclusion Criteria:

* Not able to sufficiently understand the patient information and questionnaire (German language)
* MS Patients with long-term antibiotic prophylaxis
* MS Patients with known primary immunodeficiency, under chemotherapy due to any malignancy or HIV infection.

Study Locations (1)

University Hospital Basel, Department of Neurology
Basel, Switzerland

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Prospective Stratification of Infectious Risks in Multiple Sclerosis | Huxley